Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine vs Rectal Misoprostol for Blood Loss in Cesarean Section
NCT03723031Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Nov 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Cairo University. Primary endpoint: Estimated Blood Loss during and after CS at 12 hours. Status: unknown.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03723031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03723031.